Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chrysanthi Tsamadou

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
HLA|October 3, 2019
HLA-DRB4*01:14 is a null allele, and renamed HLA-DRB4*01:14NDaniel Fuerst, Chrysanthi Tsamadou, Sowmya Gowdavally, et al.
International Journal of Immunogenetics|June 10, 2021
Extended loci histocompatibility matching in HSCT-Going beyond classical HLAChristine Neuchel, Daniel Fürst, Chrysanthi Tsamadou, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|December 14, 2019
HLA Matching in Unrelated Stem Cell Transplantation up to DateDaniel Fürst, Christine Neuchel, Chrysanthi Tsamadou, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|February 29, 2020
Next-Generation Sequencing Technologies in Blood Group TypingDaniel Fürst, Chrysanthi Tsamadou, Christine Neuchel, et al.
Haematologica|November 28, 2015
Time-dependent effects of clinical predictors in unrelated hematopoietic stem cell transplantationDaniel Fuerst, Carlheinz Mueller, Dietrich W Beelen, et al.
Ejhaem|April 25, 2022
Erytra blood group analyser and kode technology testing of SARS-CoV-2 antibodies among convalescent patients and vaccinated individualsChristof Weinstock, Willy A Flegel, Kshitij Srivastava, et al.
Medrxiv : the Preprint Server for Health Sciences|September 8, 2021
Erytra Blood Group Analyser and Kode Technology testing of SARS-CoV-2 antibodies among convalescent patients and vaccinated individualsChristof Weinstock, Willy A Flegel, Kshitij Srivastava, et al.
Haematologica|January 7, 2017
Increased age-associated mortality risk in HLA-mismatched hematopoietic stem cell transplantationDaniel Fürst, Dietger Niederwieser, Donald Bunjes, et al.
Plos One|January 21, 2017
Impact of Donor Activating KIR Genes on HSCT Outcome in C1-Ligand Negative Myeloid Disease Patients Transplanted with Unrelated Donors-A Retrospective StudyChristine Neuchel, Daniel Fürst, Dietger Niederwieser, et al.
Frontiers in Immunology|December 5, 2022
Differentially induced immunity in buccal and nasal mucosae after vaccination for SARS-CoV-2: Prospects for mass scale immunity-screening in large populationsChrysanthi Tsamadou, Carolin Ludwig, Judith Scholz, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
HLA|October 3, 2019
HLA-DRB4*01:14 is a null allele, and renamed HLA-DRB4*01:14NDaniel Fuerst, Chrysanthi Tsamadou, Sowmya Gowdavally, et al.
International Journal of Immunogenetics|June 10, 2021
Extended loci histocompatibility matching in HSCT-Going beyond classical HLAChristine Neuchel, Daniel Fürst, Chrysanthi Tsamadou, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|December 14, 2019
HLA Matching in Unrelated Stem Cell Transplantation up to DateDaniel Fürst, Christine Neuchel, Chrysanthi Tsamadou, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|February 29, 2020
Next-Generation Sequencing Technologies in Blood Group TypingDaniel Fürst, Chrysanthi Tsamadou, Christine Neuchel, et al.
Haematologica|November 28, 2015
Time-dependent effects of clinical predictors in unrelated hematopoietic stem cell transplantationDaniel Fuerst, Carlheinz Mueller, Dietrich W Beelen, et al.
Ejhaem|April 25, 2022
Erytra blood group analyser and kode technology testing of SARS-CoV-2 antibodies among convalescent patients and vaccinated individualsChristof Weinstock, Willy A Flegel, Kshitij Srivastava, et al.
Medrxiv : the Preprint Server for Health Sciences|September 8, 2021
Erytra Blood Group Analyser and Kode Technology testing of SARS-CoV-2 antibodies among convalescent patients and vaccinated individualsChristof Weinstock, Willy A Flegel, Kshitij Srivastava, et al.
Haematologica|January 7, 2017
Increased age-associated mortality risk in HLA-mismatched hematopoietic stem cell transplantationDaniel Fürst, Dietger Niederwieser, Donald Bunjes, et al.
Plos One|January 21, 2017
Impact of Donor Activating KIR Genes on HSCT Outcome in C1-Ligand Negative Myeloid Disease Patients Transplanted with Unrelated Donors-A Retrospective StudyChristine Neuchel, Daniel Fürst, Dietger Niederwieser, et al.
Frontiers in Immunology|December 5, 2022
Differentially induced immunity in buccal and nasal mucosae after vaccination for SARS-CoV-2: Prospects for mass scale immunity-screening in large populationsChrysanthi Tsamadou, Carolin Ludwig, Judith Scholz, et al.
Pageof 3